A multi-center, randomized, placebo- and active-controlled,parallel-group, 24-week proof of concept and dose-findingstudy to evaluate efficacy, safety, and tolerability ofXXB750 in patients with heart failure. CXXB750A12201

Project: Research project

Project Details

Description

A multi-center, randomized, placebo- and active-controlled, parallel-group, 24-week proof of concept and dose-finding study to evaluate efficacy, safety, and tolerability of XXB750 in patients with heart failure. CXXB750A12201
StatusActive
Effective start/end date1/18/2412/1/27

Funding

  • NOVARTIS PHARMACEUTICALS CORPORATION

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.